With industry waiting on the FDA to issue regs for CBD products, the agency instead released a statement explaining why it has not yet done so—including fears that the trendy cannabinoid may cause liver damage. But advocates charge that the claim is based on faulty research.
Recent comments
15 weeks 3 days ago
19 weeks 4 days ago
21 weeks 2 days ago
21 weeks 2 days ago
33 weeks 5 days ago
39 weeks 3 days ago
50 weeks 3 days ago
51 weeks 2 days ago
1 year 5 days ago
1 year 1 week ago